Rep. Harshbarger Introduces Bill to Ban Abortion Pill Mifepristone and Allow Lawsuits Against Makers
This bill is currently in the early stages of the legislative process and has been sent to two House committees for review. It is considered active, but no further hearings or votes have been scheduled at this time.
Part of: story →Companion bill: Sen. Hawley Introduces Bill to Ban Abortion Pill Mifepristone and Allow Lawsuits Against Makers →This is a highly partisan bill that would likely face a filibuster in the Senate or a veto from the White House.
This bill would eliminate the most commonly used method of medication abortion in the United States. Mifepristone is used in more than half of all abortions nationwide, so banning it would force anyone seeking to end a pregnancy to rely on surgical procedures or less common drug regimens. This would significantly reduce access to abortion care, especially for people in rural areas or states with limited clinic availability, and could delay care for those who need time to arrange surgical alternatives.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes have been recorded for this legislation yet.
Sen. Josh Hawley (R-Mo.) announced the Safeguarding Women from Chemical Abortion Act, which would revoke FDA approval of mifepristone for abortion. The bill includes a private right of action for women to sue manufacturers for damages, though its legislative path remains uncertain.
The Safeguarding Women from Chemical Abortion Act seeks to permanently revoke FDA approval of mifepristone for pregnancy termination. The bill would still allow the medication for Cushing syndrome under different branding, forcing pharmacists to manage the drug under divergent legal frameworks.
Senator Josh Hawley introduced legislation to ban mifepristone for chemical abortions, citing safety concerns. The act would withdraw FDA approval and establish a federal tort for harm caused by the drug, allowing women to make claims against the government and manufacturers.
Document Type
Congressional Bill
Official Title
Safeguarding Women from Chemical Abortion Act
Analysis generated by AI. Always verify with official sources.